---
title: "SL PHARM released its performance for the first half of the year, with a net profit attributable to the parent company of 121 million yuan, an increase of 309.08%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/254476181.md"
description: "According to the Zhitong Finance APP, SL PHARM released its semi-annual report for 2025, showing an operating income of 305 million yuan, a year-on-year decrease of 22.24%. The net profit attributable to shareholders of the listed company was 121 million yuan, a year-on-year increase of 309.08%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 26.044 million yuan, a year-on-year decrease of 78.42%. The basic earnings per share were 0.12 yuan"
datetime: "2025-08-25T15:02:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/254476181.md)
  - [en](https://longbridge.com/en/news/254476181.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/254476181.md)
generator: "portal-rs"
---

# SL PHARM released its performance for the first half of the year, with a net profit attributable to the parent company of 121 million yuan, an increase of 309.08%

According to the Zhitong Finance APP, SL PHARM (002038.SZ) released its semi-annual report for 2025, reporting an operating income of 305 million yuan, a year-on-year decrease of 22.24%. The net profit attributable to shareholders of the listed company was 121 million yuan, a year-on-year increase of 309.08%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 26.044 million yuan, a year-on-year decrease of 78.42%. The basic earnings per share were 0.12 yuan

### Related Stocks

- [002038.CN](https://longbridge.com/en/quote/002038.CN.md)

## Related News & Research

- [5 things to know about the Chinese e-commerce juggernaut Shein ahead of its IPO](https://longbridge.com/en/news/296771842.md)
- [Cattle Prices Struggle but Get Some Bullish USDA Data; Lean Hog Prices Mired at 12-Month Low](https://longbridge.com/en/news/296804867.md)
- [Bessent's bond gambit aimed at calming markets is instead stirring inflation worries](https://longbridge.com/en/news/296642975.md)
- [Livzon Pharma buys 3.5% Xinbeijiang Pharma stake for RMB 106.7 million](https://longbridge.com/en/news/296601614.md)
- [14:45 ETInventHelp Inventor Develops New Travel Toothbrush (FJK-601)](https://longbridge.com/en/news/296820070.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**